SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $242,000 | +4.8% | 1,425 | -28.8% | 0.04% | -11.4% |
| Q1 2020 | $231,000 | -60.6% | 2,000 | -61.1% | 0.04% | -46.3% |
| Q4 2019 | $587,000 | +33.7% | 5,135 | 0.0% | 0.08% | +20.6% |
| Q3 2019 | $439,000 | +23.7% | 5,135 | 0.0% | 0.07% | +51.1% |
| Q2 2019 | $355,000 | -5.6% | 5,135 | 0.0% | 0.04% | -15.1% |
| Q1 2019 | $376,000 | +29.2% | 5,135 | 0.0% | 0.05% | +8.2% |
| Q4 2018 | $291,000 | -26.5% | 5,135 | 0.0% | 0.05% | -15.5% |
| Q3 2018 | $396,000 | +16.1% | 5,135 | 0.0% | 0.06% | -6.5% |
| Q2 2018 | $341,000 | +36.4% | 5,135 | +7.5% | 0.06% | +37.8% |
| Q1 2018 | $250,000 | -2.0% | 4,775 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $255,000 | -1.9% | 4,775 | 0.0% | 0.04% | -4.3% |
| Q3 2017 | $260,000 | – | 4,775 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |